0001209191-21-026247.txt : 20210409
0001209191-21-026247.hdr.sgml : 20210409
20210409163631
ACCESSION NUMBER: 0001209191-21-026247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210408
FILED AS OF DATE: 20210409
DATE AS OF CHANGE: 20210409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legault Pierre
CENTRAL INDEX KEY: 0001391045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 21818246
MAIL ADDRESS:
STREET 1: P.O. BOX 1028
STREET 2: C/O STONE MANAGEMENT LLC
CITY: BERWYNE
STATE: PA
ZIP: 19312
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-08
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001391045
Legault Pierre
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2021-04-08
4
M
0
24838
8.74
A
24838
D
Ordinary Shares
2021-04-08
4
S
0
12500
32.00
D
12338
D
Ordinary Shares
2021-04-08
4
S
0
12099
31.40
D
239
D
Ordinary Shares
2021-04-08
4
S
0
239
32.13
D
0
D
Stock Option (Right to Buy)
8.74
2021-04-08
4
M
0
24838
0.00
D
2029-04-25
Ordinary Shares
24838
173312
D
This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.37265 to GBP 1.00 as of April 8, 2021.
Shares were sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to
$31.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.16 inclusive.
This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.
/s/ Lee Kalowski, Attorney-in-Fact
2021-04-09